PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer.
- DOI
- 10.1016/j.xcrm.2026.103002
- Published
- 2026-08-21
- Container
- Cell Rep Med
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2026.103002,
title = {PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer.},
author = {Lin L and Moradi N and Lähdeniemi IA and Laitinen HK and Alsaed B and Lahtinen L and Lopez T and Jansouz S and Knott A and Soroko KM and Ilonen I and Gokhale PC and Jänne PA and Haikala HM.},
year = {2026},
journal = {Cell Rep Med},
doi = {10.1016/j.xcrm.2026.103002},
url = {https://doi.org/10.1016/j.xcrm.2026.103002}
}RIS
TY - JOUR TI - PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer. AU - Lin L AU - Moradi N AU - Lähdeniemi IA AU - Laitinen HK AU - Alsaed B AU - Lahtinen L AU - Lopez T AU - Jansouz S AU - Knott A AU - Soroko KM AU - Ilonen I AU - Gokhale PC AU - Jänne PA AU - Haikala HM. PY - 2026 JO - Cell Rep Med DO - 10.1016/j.xcrm.2026.103002 UR - https://doi.org/10.1016/j.xcrm.2026.103002 ER -
APA
L, L., N, M., IA, L., HK, L., B, A., L, L., T, L., S, J., A, K., KM, S., I, I., PC, G., PA, J., & HM., H. (2026). PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer.. Cell Rep Med. https://doi.org/10.1016/j.xcrm.2026.103002
Source records
- europe-pmc · retrieved 2026-09-26T11:43:13.044Z